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A B S T R A C T
The molecular interaction between chemicals and proteins often promotes alteration of cellular function. One of 
the challenges of the toxicology is to predict the impact of exposure to chemicals. Assessing the impact of 
exposure implies to understand their mechanism of actions starting from identification of specific protein targets 
of the interaction. Current methods can mainly predict effects of characterized chemicals with knowledge of its 
targets, and mechanism of actions. Here, we show that proteome-wide thermal shift methods can identify 
chemical-protein interactions and the protein targets from bioactive chemicals. We analyzed the identified 
targets from a soluble proteome extracted from zebrafish embryo, that is a model system for toxicology. To 
evaluate the utility to predict mechanism of actions, we discussed the applicability in four cases: single chem-
icals, chemical mixtures, novel chemicals, and novel drugs. Our results showed that this methodology could 
identify the protein targets, discriminate between protein increasing and decreasing in solubility, and offering 
additional data to complement the map of intertwined mechanism of actions. We anticipate that the proteome 
integral solubility alteration (PISA) assay, as it is defined here for the unbiased identification of protein targets of 
chemicals could bridge the gap between molecular interactions and toxicity pathways. 
Significance: One of the challenges of the environmental toxicology is to predict the impact of exposure to 
chemicals on environment and human health. Our phenotype should be explained by our genotype and the 
environmental exposure. Genomic methodologies can offer a deep analysis of human genome that alone cannot 
explain our risks of disease. We are starting to understand the key role of exposure to chemicals on our health and 
risks of disease. Here, we present a proteomic-based method for the identification of soluble proteins interacting 
with chemicals in zebrafish embryo and discuss the opportunities to complement the map of toxicity pathway 
perturbations. We anticipate that this PISA assay could bridge the gap between molecular interactions and 
toxicity pathways.   
1. Introduction 
We are exposed to individual chemical or mixtures via air, water, 
food, and consumables and it is difficult to evaluate how the exposure 
would affect to human health. Toxicology aims to predict the impact of 
exposure to chemicals by understanding the possible mechanism of ac-
tions of the bioactive compounds on cells. Scientists, regulatory 
agencies, and public health authorities have agreed about our partial 
understanding of possible effects of exposure to chemicals and in 
particular, complex mixtures. Therefore exploring methodologies with 
larger capability to analyze chemicals and identify possible targets could 
provide a comprehensive understanding of the impact of exposure to 
chemicals, and predicting adverse outcome pathways and health out-
comes [1]. 
Current methods in toxicology have achieved comprehensive 
knowledge from the main toxicity pathways and detailed structure in-
formation its receptor for a few chemical and classes [2]. When the 
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current knowledge or structural similarity could not lead to any 
educated guess, individual assays are applied, such measuring the 
alteration on the membrane stability, mitochondrial activity or increases 
in free radical species [3]. Targeted assays could only be applied to 
confirmed mechanism of action, such as measuring the induction of 
chemical-metabolizing enzymes that can have significant consequences 
on toxicity [4]. In that direction, collaborative projects like Tox21 have 
been working since 2008 for the developing and validation of individual 
cell-based assays to rapid screen for individual chemicals. The Tox21 
project has complied over 100 bioassays that are used to screen several 
thousands of chemicals until now [3]. Unfortunately, there is not a 
simple solution to evaluate over 100,000 chemicals that are included in 
consumables, agriculture, manufactures, and industrial activities [3]. At 
the European Union, the legislation is based on the registration, evalu-
ation, authorization, and restriction of chemicals in the frame of REACH 
regulation (EC2006) that is directly submitted by the producers. There is 
a recent agreement that the process of evaluation has serious limitation 
to cope with the amount of chemicals and diversity of mixtures [5]. 
More than 2 decades ago the major challenge of toxicology was the 
safety evaluation of chemical mixtures and determination of the lowest 
concentration of the individual chemicals of no health concern [6]. The 
mechanism of action of chemicals mixtures are not easily explained but 
a review from recent studies found that are relatively rare synergisms 
[7]. The studies of cocktail of chemicals have been leading by a few 
chemical classes and well-characterized combinations whereas the in-
formation from uncharacterized or more diverse combination of com-
pounds are very scarce [7]. The aim to identify mechanisms underlying 
the adverse health effects of exposure to chemical mixtures is still 
pending [8]. Thus, the implementation of the current toxicological ap-
proaches with new methods that could rapidly evaluate the cellular 
response and efficiently predict the risk of exposure to chemicals is very 
timely [9]. 
Any strategy to assess the effects of exposure starts by elucidating the 
mechanism of action of the bioactive compound in a cellular milieu. It 
involves understanding the molecular interaction between the chemical 
and the molecular drivers of cellular functions, the proteins. The pro-
teins are shaped to interact with small molecules in the cells to modulate 
cellular response [10]. Thus, proteins are prompted to establish mo-
lecular interaction with chemical compounds that unexpectable enter in 
the cell. The molecular interaction between chemicals with proteins 
initiates most of the alteration of cellular functions. Several proteomics- 
based methods have recently developed with the aiming to scrutinizing 
any proteome for specific protein-drug interactions that would define 
the targets of interest, reducing to a small numbers of candidate ligands 
to evaluate in more details through additional assays [11–14]. Those 
methods have received the interest of pharma [15,16] as well as medi-
cine to study basic biological processes such as capturing intracellular 
signaling [17–19]. 
The first high-throughput assay for drug target deconvolution, 
named cellular thermal shift assay, was based on the application of the 
thermal shift principles at a proteome scale coupled with antibody-based 
identification [20]. However, key implementation that increased the 
opportunities of the proteome-wide thermal shift assay was the intro-
duction of mass spectrometry for protein identification. The thermal 
proteome profiling (TPP) method incorporated mass spectrometry- 
based proteomic analysis by isobaric tandem mass tags increasing the 
high-throughput and the specificity of drug targets identified. The most 
common goal with this method is to find protein with alteration in the 
thermal profile [11]. The application of TPP to novel bioactive com-
pounds, partially hydrophobic, pointed out the importance of a soluble 
proteome free from microsomes at the thermal shift assay. The hydro-
phobic compounds, as many chemicals, could easily integrate into the 
lipidic microsomal vesicles changing the concentration of compounds 
and proteome under the thermal shift assay. The modification intro-
duced in the bioactive thermal proteome profiling (bTPP) method fa-
cilitates its application to chemicals [21]. Chemical compounds, such as 
endocrine disrupting chemicals, that are known to bind to proteins 
including receptors are chemical compounds have been considered for 
Abbreviation
PISA Proteome integral solubility alteration 
TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin 
BPA bisphenol A 
TPP thermal proteome profiling 
bTPP bioactive thermal proteome profiling 
REACH registration, evaluation, authorization and restriction 
regulation 
dpf days post fertilization 
POP persistent organic pollutant 
EDC endocrine disruptor compound 
hpa 132-hydroxy-pheophytin a 
DMSO dimethyl sulfoxide 
nLC-MS/MS nano liquid chromatography-tandem mass 
spectrometry analysis 
FASP Filter aided sample preparation 
ACN acetonitrile 
FA formic acid 
FDR false discovery rate 
ER endoplasmic reticulum 
Trap1 TNF receptor-associated protein 1 
Calr3b Calreticulin 3b precursor 
Calr Calreticulin 
Mdka midkine a 
S100w s100 calcium-binding protein w 
RhoA-D Rho-related GTP-binding protein RhoA-D 
L1cama neural adhesion molecule L1.2 
Iglon5 zgc:110372 
Tnni2a.4 fast muscle troponin I 
Hrc histidine-rich calcium-binding protein 
Aldh2.2 aldehyde dehydrogenase 2 
Pkmb pyruvate kinase 
Gaphs glyceraldehyde-3-phosphote dehydrogenase 
Npc2 npc intracellular cholesterol transporter 2 
Ckmt2a creatine kinase, mit 2a 
Dbi diazepam-binding inhibitor 
Glo1 glyoxalase1 
Mat2aa methionine adenosyltransferase II 
Fkbp9 peptidylprolyl isomerase 
Anxa2b annexin 
Nap1l1 neuronal system, Nap1l1 protein 
Crygm2d14 lens proteins crystallin gamma M2d14 
Crygm2d2 crystalline gamma M2d2 
Tpma tropomyosin alpha-1 chain 
Rplp1 ribosomal protein large P1 
Negr1 kilon 
Luc7l LUC7-like 
Cfhl4 complement factor H-like 4 
Ubqln4 ubiquitilin 4 
Grk7a rhodopsin kinase grk7a 
Mtap ribosomal protein S27a; S-methyl-5′-thioadenosine 
phosphorylase 
ER endoplasmic reticulum 
Prkcsh Protein kinase C substrate 80 K-H 
Lamb2 laminin beta 2  
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evaluation by thermal proteome profiling approaches in cell lines [22]. 
Finally, the proteome integral solubility alteration (PISA) method 
moved one step forward eliminating the sigmoidal fitting of the protein 
melting curves. In PISA method, the main concept is to measure curve 
integrals under perturbation and control instead of the curve shape 
parameters [12]. 
Aiming to find a high-throughput methodology to tackle this chal-
lenge, we evaluated the applicability of the PISA assay to identify the 
proteins interacting with chemicals from the soluble proteome of 
zebrafish embryos. Toxicology also requires to circumvent the problem 
of use laboratory animals, and zebrafish (Danio rerio) embryo, a research 
model (zfin.org), has been considered sensitive enough to provide data 
to risk assessment [23] and it is considered an alternative to animal 
testing by the Eu Commission [24]. Here, we presented the application 
of PISA assay to identify protein targets, that are the molecular links to 
predict mechanism of actions, and we discussed four cases: i) a single 
chemical; ii) a simple chemical mixture; iii) a novel chemical from 
marine biodiscovery, and iv) a novel drug. This study with zebrafish 
embryo proteome evaluates the opportunities of PISA assay for human 
and environmental toxicology and remarks some differences from its 
application for drug target deconvolution. 
2. Materials and methods 
2.1. Sample preparation 
Reagents and medium were purchased from Sigma-Aldrich unless 
otherwise noted. PBS was purchased from Trevigen. Zebrafish (Danio 
rerio) embryos from strain AB were obtained from zebrafish core facility, 
Karolinska Institute, Stockholm, Sweden. Embryos were collected 5 days 
post fertilization (dpf) and stored at − 80 ◦C until protein extraction. The 
work with zebrafish embryos under 5 dpf can be considered an alter-
native to animal testing according to the Eu Commission Directive from 
20/09/2010 where experiments with earliest life-stages of zebrafish up 
to 5 dpf are not regulated for animal experimentation [24]. 
2.2. Selection of different test compounds and concentrations 
The bioactive compounds analyzed in this study and the corre-
sponding concentrations were: i) 25 nM 2,3,7,8 tetrachlorodibenzo-p- 
dioxin (TCDD) a persistent organic pollutant (POP) and endocrine dis-
ruptor compound (EDC); ii) a chemical mixture composed by three POPs 
and EDCs with different mechanisms of action: 25 nM TCDD, 10 μM 
alpha-endosulfan and 50 μM bisphenol A (BPA); iii) 9.2 μM 132-hy-
droxy-pheophytin a (hpa), isolated from the marine cyanobacterial 
strain LEGE 07175 and the growing conditions, extraction, isolation, 
and characterization has been previously reported [25]; iv) 10 μM EG- 
011 (PCT/EP2018/057678) a new small molecule, with in vitro and in 
vivo anti-cancer activity in lymphoma models. 
The rationale for the selection of the test compounds was to include 
chemicals previously studied individually or as mixtures. Therefore, we 
included compounds and concentrations from previously studied 
mixture for in vitro exposures to human hepatic cell line HepRG. This 
mixture originally contained TCDD, alpha-endosulfan, and we added 
BPA to gain in complexity. Moreover, this mixture was selected due to 
their relevance on human and environmental health, as all of them are 
POPs and EDCs. Further, TCDD and alpha- endosulfan can be found in 
the environment as a mixture because dioxins (TCDD) may contaminate 
chlorinated industrial products, as pesticides (alpha-endosulfan). Con-
centration selection was based on the translation of external intakes into 
internal doses in hepatic cells [26]. The hpa is a novel compound from 
marine biodiscovery recently characterized [25]. The concentration has 
selected was the EC50 based on phenotypic screening and from our 
previous experiments of thermal proteome profiling with hepatocytes 
cell lines [21,25]. Finally, EG-011 has been recently developed and it is 
an early phase of characterization. The concentration utilized was the 
EC50 provided by the developers of the compound. 
2.3. PISA assay 
Zebrafish embryos were resuspended in a buffer containing 20 mM 
Tris-HCl and 20 mM NaCl, at pH 8.5, and mechanically homogenized 
using a TissueLyser (Qiagen) for 3 min at 25 Hz. The cells were lysed by 
sonication in cycles of 10s/5s for 3 min at 6–10 μm amplitude at 50% 
intensity from an exponential ultrasonic horn of 3 mm in a Soniprep 150 
MSE (MSE Ltd., Lower Sydenham, London, UK). The insoluble parts 
were sedimented by centrifugation at 100,000g for 60 min at 4 ◦C [21]. 
Protein concentration was determined by BCA assay [27]. The soluble 
proteome was used to perform the PISA assay, as described in Gaetani 
et al. [12] with some modifications. Briefly, the soluble proteome and 
the studied chemical were incubated for 10 min at 25 ◦C. The incubation 
was performed with the following compounds at the corresponding 
concentrations: i) 25 nM TCDD, ii) 25 nM TCDD, 10 μM alpha- 
endosulfan, 50 μM BPA, iii) 9.2 μM hpa, and iv) 10 μM EG-011. The 
control samples were incubated in the presence of the vehicle, dimethyl 
sulfoxide (DMSO), utilized for the solubilization of the compounds. 
Fifteen specific temperatures were selected for the thermal assay: 37, 40, 
43, 46, 48, 50, 51, 52, 53, 54, 56, 58, 61, 64 and 67 ◦C. These temper-
atures were selected to ensure that at least 90% of the studied proteins 
have their melting point within this range [11]. Aliquots containing 
25 μg of protein (one for each of the temperatures in the entire range 
covered in the thermal shift assay) were independently heated at the 
corresponding temperature for 3 min, followed by 3 min at room tem-
perature. The samples were centrifuged at 100,000g for 20 min at 4 ◦C, 
to remove the proteins that had altered in solubility after the thermal 
shift assay [11]. The collection of soluble fractions in the supernatants 
were processed using a general bottom-up proteomics workflow and the 
purified peptides were analyzed by label-free nano liquid 
chromatography-tandem mass spectrometry analysis (nLC-MS/MS). 
Three biological replicates were performed for each experiment [28]. 
2.4. Filter aided sample preparation (FASP) 
The samples were digested following the FASP method. First, the 
protein samples corresponding to the supernatants after centrifugation 
were prepared with SDT buffer (2% SDS, 100 mM Tris-HCl, pH 7.6 and 
100 mM DTT), according to Wísniewski et al. (2012) [29]. To perform 
FASP, the samples were diluted with 200 μl of 8 M urea in 0.1 M Tris/ 
HCl, pH 8.5 (UA) in 30 kDa microcon centrifugal filter units. The filter 
units were centrifuged at 14,000 g for 15 min at 20 ◦C. The concentrated 
samples were diluted with 200 μl of UA and centrifuged at 14,000 g for 
15 min at 20 ◦C. After discharging the flow-through 100 μl of 0.05 M 
iodoacetamide was added to the filter units, mixed for 1 min at 600 rpm 
on a thermo-mixer, and incubated static for 20 min in dark. The solution 
was drained by spinning the filter units at 14,000 g for 10 min. The filter 
units were washed three times with 100 μl buffer UA and centrifuged at 
14,000 g for 15 min. The filter units were washed three times with 100 μl 
of 50 mM ammonium bicarbonate. Endopeptidase trypsin solution in the 
ratio 1:100 was prepared with 50 mM ammonium bicarbonate, 
dispensed, and mixed at 600 rpm in the thermomixer for 1 min. These 
units were then incubated in a wet chamber at 37 ◦C for about 16 h to 
achieve effective trypsinization. After 16 h of incubation, the filter units 
were transferred into new collection tubes. To recover the digested 
peptides, the tubes were centrifuged at 14,000 g for 10 min. Peptide 
recovery was completed by rinsing the filters with 50 μl of 0.5 M NaCl 
and collected by centrifugation. The samples were acidified with 10% 
formic acid (FA) to achieve pH between 3 and 2. The desalting process 
was performed by reverse phase chromatography in C18 top tips using 
acetonitrile (ACN; 60% v/v) with FA (0.1% v/v) for elution, and vacuum 
dried to be stored at − 80 ◦C till further analysis. 
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2.5. Nano LC-MS/MS analysis 
The desalted peptides were reconstituted with 0.1% FA in ultra-pure 
milli-Q water and the concentration was measured using a Nanodrop 
(Thermo Scientific). Peptides were analyzed in a QExactive quadrupole- 
orbitrap mass spectrometer (Thermo Scientific). Samples were separated 
using an EASY nLC 1200 system (Thermo Scientific) and tryptic peptides 
were injected into a pre-column (Acclaim PepMap 100 Å, 75 um × 2 cm) 
and peptide separation was performed using an EASY-Spray C18 
reversed-phase nano LC column (PepMap RSLC C18, 2 um, 100 Å, 75 
um × 25 cm). A linear gradient of 6 to 40% buffer B (0.1% FA in ACN) 
against buffer A (0.1% FA in water) during 78 min and 100% buffer B 
against buffer A till 100 min, was carried out with a constant flow rate of 
300 nl/min. Full scan MS spectra were recorded in the positive mode 
electrospray ionization with an ion spray voltage power frequency (pf) 
of 1.9 kV (kV), a radio frequency lens voltage of 60 and a capillary 
temperature of 275 ◦C, at a resolution of 30,000 and top 15 intense ions 
were selected for MS/MS under an isolation width of 1.2 m/z units. The 
MS/MS scans with higher energy collision dissociation fragmentation at 
normalized collision energy of 27% to fragment the ions in the collision 
induced dissociation mode. 
2.6. Peptide and protein identification and quantification 
Proteome Discoverer (v2.1, Thermo Fischer Scientific) was used for 
protein identification and quantification. The MS/MS spectra (. raw 
files) were searched by Sequest HT against the Zebrafish database from 
Uniprot (UP000000437; 46,847 entries). A maximum of 2 tryptic 
cleavages were allowed, the precursor and fragment mass tolerance 
were 10 ppm and 0.6 Da, respectively. Peptides with a false discovery 
rate (FDR) of less than 0.01 and validation based on q-value were used as 
identified. The minimum peptide length considered was 6 and the FDR 
was set to 0.1. Proteins were quantified using the average of top three 
peptide MS1-areas, yielding raw protein abundances. Common con-
taminants like human keratin and bovine trypsin were also included in 
the database during the searches for minimizing false identifications. 
The mass spectrometry proteomics data have been deposited to the 
ProteomeXchange Consortium via the PRIDE [30] partner repository 
with the dataset identifier PXD021670. 
2.7. Analysis of PISA assay 
According to the original publication of this method [12], PISA assay 
measures the protein abundance (Sm) of each pooled sample instead 
extracting the relative melting temperatures Tm by curve fitting, as in 
TPP. Therefore, the protein abundance represents the integral of the 
area under its melting curve within the used temperature interval. If Sm 
is the value for the control sample and Sm’ is the corresponding value for 
the exposed sample, then the PISA analogue of ΔTm is ΔSm = Sm’-Sm 
[12]. To obtain ΔSm, we normalized the quantitative values for each 
protein on the average value for the control sample. Two-tailed Stu-
dent’s t-test (with equal or unequal variance depending on F-test) was 
applied to calculate p-values. Proteins with p-values < 0.05 were 
considered as protein targets. The data was represented in a volcano plot 
combining the calculated ΔSm and p-values, that facilitated to visualize 
the protein targets [12]. 
2.8. Pathway analysis 
Pathway analysis was performed by protein interaction enrichment 
using STRING 11.0 [31]. Protein sequences were BLAST searched 
against the RefSeq human databases, and BLAST results were analyzed 
in a map of functional pathways. 
3. Results 
3.1. Implementation of PISA assay to analyze the soluble proteome from 
zebrafish embryo 
The zebrafish embryo at the stage 5 dpf is broadly utilized in toxi-
cology to assess the effects of drugs and substances and to understand 
mechanisms of toxicity poorly understood [24,32]. Here, the soluble 
proteome from zebrafish embryos was analyzed by PISA assay to iden-
tify proteins interacting with chemicals. The solubilization conditions 
were selected to maintain during the thermal shift assay two parameters 
invariable: proteome, and the concentration of chemicals. This is an 
important consideration for this methodology that aim to identify the 
protein-chemical interactions based on the alteration on protein 
solubility. 
Firstly, several buffers were tested and a buffer contained 20 mM 
Tris-HCl and 20 mM NaCl, at pH 8.5 was selected. The proteome in this 
solution rendered the highest efficiency and reproducibility in the pro-
tein extraction, facilitated proteins in their native structure in solution, 
the stability of the proteome through the thermal assay [21]. This buffer 
yield between 2 and 3 μg protein/embryo after disrupting the tissues by 
mechanical press utilizing a homogenizer or a grinder with abrasive 
glass beads. The cell lysed with ultrasonic horn on top of the initial 
shearing process increased the extraction from 3 to 5.3 μg/embryo and 
this was the selected method for the study (Table 1). Secondary, the 
hydrophobic compounds, such as many chemical compounds, will tend 
to incorporate into the lipids from microsomes reducing the active 
concentration of compound in solution [33]. Therefore, the soluble 
proteome was obtained after sedimentation of the microsomal vesicles 
with the classical fractionation step at 100,000 g for 60 min at 4 ◦C 
[34,35] (Fig. 1). 
3.2. Systematic analysis of chemical-protein interactions in the soluble 
proteome from zebrafish embryos 
We evaluated the PISA assay to identify the proteins interacting with 
individual chemicals using TCDD as test compound and the zebrafish 
embryo soluble proteome. This compound is classified as persistent 
environmental pollutant, and as EDC. This chemical offers a well-known 
mechanism of toxicity based on the initial interaction to aryl hydro-
carbon receptor. This protein could not be detected in the proteome that 
was analyzed in this study. We remind that the focus of this study is the 
unbiased identification of any interaction between the chemicals and all 
the proteins in the studied proteome. We used three biological replicates 
per condition, including the chemical perturbation with TCDD at 25 nM, 
and the corresponding control with a vehicle. 
The soluble proteome analyzed yielded 2422 proteins identified and 
quantified across the replicates, and 840 proteins quantified in all three 
replicates were included in the PISA analysis. The analysis of the TCDD- 
protein interactions identified 9 protein targets. It has been evaluated 
the targets increasing and decreasing in solubility named as stabilized or 
destabilized proteins (Table S1). The protein targets can be depicted 
from the volcano plot (Fig. 2a). Six out them were destabilized, being 
Zgc:162944, TNF receptor-associated protein 1 (Trap1), Calreticulin 3b 
precursor (Calr3b), and Calreticulin (Calr), the ones with the highest 
significance negative difference in ΔSm compared to control. The 
remaining, midkine a (Mdka), s100 calcium-binding protein w (S100w) 
were destabilized and Rho-related GTP-binding protein RhoA-D (RhoA- 
D), neural adhesion molecule L1.2 (L1cama) and zgc:110372 (Iglon5) 
were stabilized by TCDD in the PISA assay. The analysis of the functional 
protein association of the targets by STRING identified 3 interactions 
with confidence score higher than 0.5 and 3 interactions with low 
confidence (score < 0.3). Trap 1, Calr, and Calr3b (Calrl) interactions 
corresponded to the ones with the highest confidence (Fig. 2b). After 
analyzing the network pathways connected with the identified targets, 
and the pathways connectivity, we can predict that TCDD-proteins 
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binding events can interfere developmental processes on zebrafish em-
bryos, including protein folding, cell adhesion, axonal growth, and 
neural tube formation (Fig. 2c, Table S1). 
3.3. Systematic analysis of chemical mixture-protein interactions in the
soluble proteome from zebrafish embryos
After identifying the proteins interacting with a single chemical, we 
evaluated the applicability of the PISA method to identify the proteins 
interacting with a chemical mixture composed by TCDD, alpha- 
endosulfan, and BPA. 
The soluble proteome analyzed yielded 2364 proteins identified and 
quantified across the biological replicates, and 768 proteins quantified 
in all three replicates were analyzed in the PISA assay. In total, 44 
protein targets were identified corresponding to 42 proteins that 
decreased in solubility, and 2 proteins that increased in solubility 
(Fig. 3a). The proteins with the highest significance negative difference 
in ΔSm compared to control were fast muscle troponin I (Tnni2a.4) and 
Table 1 
Cell disruption techniques and factors evaluated to extract protein under native conditions from 5dpf zebrafish embryos.  














No 20 mM Tris-HCl, 20 mM NaCl, 
pH = 8.5 
60 41.5 ± 3.5 2.2 ± 0.5 90.2 ± 11.0 1.8 ± 0.2 
Grinding with abrasives (10 
beads - 0.1 mm) 
No 20 mM Tris-HCl, 20 mM NaCl, 
pH = 8.5 
100 79.0 ± 0 0.8 ± 0 63.8 ± 3.9 1.3 ± 0 
Grinding with abrasives (10 
beads - 0.1 mm) 
No 20 mM Tris-HCl, 20 mM NaCl, 
pH = 8.5 
125 94.0 ± 0 1.0 ± 0.1 98.6 ± 4.9 2.0 ± 0.1 
Grinder (16 beads - 0.1 mm) No 20 mM Tris-HCl, 20 mM NaCl, 
pH = 8.5 
150 141.5 ± 0.7 1.2 ± 0 172.6 ± 5.9 3.5 ± 0.1 
Grinding with abrasives (16 
beads - 0.1 mm) 
No 20 mM Tris-HCl, 20 mM NaCl, 
pH = 8.5 
200 166.5 ± 3.5 0.9 ± 0 150.7 ± 9.2 3.0 ± 0.2 
Grinding with abrasives (16 
beads - 0.1 mm) 
No 10 mM sodium phosphate, 
145 mM NaCl, pH = 7.4 (PBS) 
150 141.0 ± 1.4 0.5 ± 0.2 69.8 ± 23.4 1.4 ± 0.5 
Grinding with abrasives (16 
beads - 0.1 mm) 
Sonication 20 mM Tris-HCl, 20 mM NaCl, 
pH = 8.5 
150 139.5 ± 0.7 1.9 ± 0.1 265.0 ± 13.8 5.3 ± 0.3 
All the trials were performed with 50 embryos. Instruments utilized: grinder type TissueLyser, 25 Hz, during 3 min; homogenizer type MiniPotter, 1 min strokes on bath 
ice; and sonicator type, ultrasonic horn of 3 mm, amplitude 6–10 μm. 
Fig. 1. Workflow of PISA method including modifications in the definition of the soluble fraction. The soluble proteome analyzed by the thermal shift assay in this 
study was obtained after sedimentation of microsomal vesicles by centrifugation at 100,000 g for 60 min as previous described [21]. 
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histidine-rich calcium-binding protein (Hrc). Three groups of protein 
interactions with highest confidence (score > 0.9) were identified after 
STRING analysis of protein targets and 2 groups corresponded to in-
teractions with Tnni2a.4 and Hrc. Other targets protein kinase C sub-
strate 80 K-H (Prkcsh) and laminin beta 2 (Lamb2) could also predict 
altering pathways (Fig. 3b, Table S2). There was another group of tar-
gets also identified in the only TCDD case such as Trap1 and Calr3b. In 
addition, some ribosomal proteins are also expected to find among the 
targets as those proteins expressed not identically but in all the tissues 
[36], and are directly involved in tissue biogenesis in the case of an 
organism in developmental stages [37]. Altogether, the protein targets 
identified can be used to predict the interference of the chemical mixture 
on several biological pathways specially muscle contraction, protein 
metabolism and turnover, and cell adaptation to stress (Fig. 3c). 
3.4. Systematic analysis of novel compound-protein interactions in the
soluble proteome from zebrafish embryos
Chemical compounds extracted from marine biomass are thoroughly 
examined aiming to explore its beneficial or harmful effects. We tested 
hpa, a partially characterized compound extracted from a marine cya-
nobacterial strain, that was selected for its potential interests as nutra-
ceutical after phenotypical screenings, and in vitro targeted assays [25]. 
We applied the PISA assay as described for previous chemicals. We 
identified 2318 proteins and the 790 proteins presented in all the bio-
logical replicates were included in the analysis. From the 40 protein 
targets identified, 37 of them corresponded to proteins decreasing in 
solubility after the thermal assay, and just 3 showed an increase in 
solubility (Fig. 4a). 
Several identified proteins were involved in metabolic pathways 
such as aldehyde dehydrogenase 2 (Aldh2.2), pyruvate kinase (Pkmb), 
glyceraldehyde-3-phosphote dehydrogenase (Gaphs), intracellular 
cholesterol transporter 2 (Npc2), creatine kinase, mit 2a (Ckmt2a), 
diazepam-binding inhibitor (Dbi), glyoxalase1 (Glo1), methionine ade-
nosyltransferase II (Mat2aa), peptidylprolyl isomerase (Fkbp9). Among 
the protein targets that showed high values of ∆Sm, structural proteins 
such as fast muscle troponins I (Tnni2a.4), and annexin (Anxa2b) were 
included. A group of targets were involved in organ-related functions 
including neuronal system, Nap1l1 protein (Nap1l1), lens proteins 
crystallin gamma M2d14 (Crygm2d14), and crystalline gamma M2d2 
Fig. 2. Protein target identified by PISA method for TCDD and soluble proteome from zebrafish embryos. The concentration in the assay was 25 nM TCDD. Sections 
of the figure: (a) volcano plot with identified targets shown in red and labeled; (b) string analyses of the protein targets, 3 interactions with medium confidence 
(0.4 < score < 0.7) and 3 interactions with low confidence (0.15 < score < 0.4); and (c) main protein targets and predicted mechanisms of action (Pathway 
representation were created by Biorender.com). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of 
this article.) 
Fig. 3. Protein targets identified by PISA method for a chemical mixture composed by TCDD, alpha-endosulfan, and BPA and the soluble proteome from zebrafish 
embryos. The concentrations in the assay were 25 nM TCDD, 10 μM alpha-endosulfan and 50 μM BPA. Sections of the figure: (a) volcano plot with identified targets 
shown in red and labeled; (b) string analyses of the protein targets, 3 groups of interactions with highest confident (score > 0.9); and (c) main protein targets and 
predicted mechanisms of action (Pathway representation were created by Biorender.com). (For interpretation of the references to colour in this figure legend, the 
reader is referred to the web version of this article.) 
V. Lizano-Fallas et al.                                                                                                                                                                                                                          
Journal of Proteomics 249 (2021) 104382
7
(Crygm2d2). In addition, several of the ubiquitous and high abundant 
proteins such as those related to translation are also among the identi-
fied targets (ribosomal family, Rps4x, Rpl5b, Rps24, zgc:114188, and 
Rpl12; Fig. 4b, Table S3). In summary, the protein targets involved in 
metabolic pathways could be connected to the preliminary observation 
from phenotyping screening of the compounds [25] (Fig. 4c). 
3.5. Systematic analysis of novel drug-protein interactions in the soluble
proteome from zebrafish embryos
In the case of novel drug under development, the target identifica-
tion is usually performed in a specific cell type and by target engagement 
assays or more recently by thermal and solubility proteome profiling 
methods. However, next step is discharging any unspecific binding to 
the non-target tissues that could be performed on a battery of cell lines 
or in vivo animal models. We suggested here to apply the proteome from 
zebrafish embryo and the PISA assay to scrutinize if there are additional 
protein interactions at non-target tissues. We evaluated this question 
with a cancer drug under development named EG-011 that aims to offer 
anti-cancer activity in lymphoma models. 
The soluble proteome identified and quantified 2360 proteins across 
the replicates, and 861 proteins were quantified in all three replicates 
were included in the data analysis. In total, 10 protein targets were 
identified: 5 stabilized, and 5 destabilized proteins (Fig. 5a). The 
Fig. 4. Protein targets identified by PISA method for hpa and the soluble proteome from zebrafish embryos. The concentration in the assay was 9.2 μM hpa. Sections 
of the figure: (a) volcano plot with identified targets shown in red and labeled; (b) string analyses of the protein targets, 15 interactions with the highest confidence 
(score > 0.9), and 23 interaction with high confidence (0.7 < score < 0.9): and (c) main protein targets and predicted mechanisms of action (Pathway representation 
were created by Biorender.com). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
Fig. 5. Protein targets identified by PISA method for EG-011 and the soluble proteome from zebrafish embryos. The concentration in the assay was 10 μM EG-011. 
Sections of the figure: (a) volcano plot with identified targets shown in red and labeled; and (b) string analyses of the protein targets, 5 interactions with low 
confidence (0.15 < score < 0.4). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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stabilized proteins were tropomyosin alpha-1 chain (Tpma), ribosomal 
protein large P1 (Rplp1), kilon (Negr1), and LUC7-like (Luc7l) and 
complement factor H-like 4 (Cfhl4) and the destabilized ones: ubiquitilin 
4 (Ubqln4), rhodopsin kinase grk7a (Grk7a), ribosomal protein S27a, S- 
methyl-5′-thioadenosine phosphorylase (Mtap) and a multispanning 
integral membrane protein without assigned function (Table S4). The 
targets were used to build a map of functional pathways only depicted a 
node around Rplp1, that is connected to Ubqln4, Rplp1, Luc7l covering 
functions around transcription, translation, and targeting protein to 
degradation (Fig. 5b). 
4. Discussion 
We discuss a few considerations for the applicability of PISA assay for 
the systematic identification of chemical-protein interactions from a 
zebrafish embryo proteome. The solutions most frequently used to 
extract proteins from those larvae contain detergents and chaotropic 
agents that could extract proteins at high yield but are not compatible 
with the principles of the thermal shift assay [38,39]. First, it is expected 
that the detergent micelles will change in size and shape in the thermal 
shift assay as the temperature increases over the detergent cloud tem-
perature [40,41]. The temperature-dependent micellar transition is 
dominated by the properties of the head groups of the detergents, and 
specially, in the case of non-ionic detergents, the most frequently used in 
this context. This transition could lead to the removal of water molecules 
associated with the polar head groups at the interface, breaking inter-
molecular hydrogen bonds, and reducing the micelle curvature to 
planar, that cause a growth of the micelles, forming long cylindrical 
micelles [41]. Second, chaotropic agents such as urea can cause protein 
carbamylation above 37 ◦C, which makes its use incompatible with a 
thermal shift assay that should increase to 67 ◦C [42]. Therefore, we 
defined the conditions to solubilize a zebrafish embryo proteome 
compatible with a thermal shift assay. 
The purpose of this study was to define a thermal shift assay for 
toxicology that should capture the thermal alteration of protein stability 
and the perturbation exclusively introduced by the chemical-protein 
interaction. Thus, the introduction of any temperature-sensitive vari-
able altering the concentration of chemical, or the intrinsic properties of 
the proteome would reduce the value of the method for the unbiased 
identification of chemical-protein targets. We observed that the soluble 
proteome described in TPP, or PISA methods contains microsomal 
vesicle in solution [11,12]. It is well-known that hydrophobic com-
pounds, such as many chemical compounds, are prompted to incorpo-
rate into the microsomal lipid vesicles. If the study of protein-chemical 
interaction is performed in a soluble proteome containing microsomes, 
the available chemical concentration in solution could decrease as the 
compound is embedded in the microsomal vesicles [33]. Moreover, 
thermal-shift assay is a scenario that mimics the temperature-induced 
membrane phase transition and fission of vesicles [43]. The thermal 
modifications in lipid fluidity and fission of the vesicles can change the 
sedimentation coefficient of the microsomes. Thus, the presence of 
lipidic vesicles in the studied proteome introduces a variable that con-
tributes to alteration of protein solubility, and it is not only based on 
chemical-protein interaction [21]. Therefore, we have eliminated the 
vesicles from our studied proteome by introducing a centrifugation step 
that sediment the microsomal membranes before the thermal shift assay. 
This protocol gained in specificity and sensitivity to study hydrophobic 
compounds [34]. 
The proteins that increased in solubility are the objective in experi-
ments for target engagement in drug discovery [20]. In our study with 
chemicals, we identified both stabilized and destabilized proteins. It has 
been studied that the increase of protein thermostability is also con-
nected an enhanced rigidity, reduction of the flexible parts of the 
structure, facilitating proteins to stay in different conformational states, 
and reducing unfolded and precipitation [44]. As conformational flexi-
bility is an essential factor for the dynamic of the molecular events, we 
hypothesized that the interactions that stabilized proteins could reduce 
the protein function [45]. Therefore, the stabilized and destabilized 
proteins interacting with chemicals could predict interference con-
nected to partial disfunction of functional pathways that is the oppos-
itive to identification of drug targets with an increase in solubility that is 
usually associated to activation of target function [12]. 
In our first study, we analyze the identified proteins interacting with 
one chemical in the zebrafish embryo soluble proteome. Three of those 
proteins, Trap1, Calr3b and Calr are chaperones involved in protein 
quality control pathways and are ubiquity distributed among tissues and 
organs. The function of Trap1, heat shock protein with ATPase activity, 
has been initially associated only to the mitochondrial transition pore 
and its integrity regulation. However, the Trap1 functional network has 
been enlarged by the discovery of the multiple subcellular localization. 
At the endoplasmic reticulum (ER) associated, the Trap1 offers a quality 
control mechanism related to proteasome subunit (TBP7) for proteins 
with mitochondrial localization [46]. This antiapoptotic activity should 
reduce the proteotoxic stress generated by accumulation of misfolded 
proteins [47]. On the other hand, Calr, and Calr3b are calcium-binding 
chaperones involved in protein folding through the glycoprotein- 
specific quality control machinery and in growth control [48–51]. In 
absence of calreticulin, misfolded proteins could accumulate driving ER 
stress. When this stress is severe and irreparable the unfolded protein 
response turns to a pro-death response through mitochondrial involve-
ment, leading apoptosis, where Trap1 could be a potential regulator 
[47,50,52]. We hypothesize that those chemical-protein interactions 
could contribute to alteration of mitochondrial integrity and apoptosis 
[46,53], and compromise ER functionality decreasing protein folding 
efficiency and Ca2+ homeostasis [54,55]. The method also identified 
Mdka and L1cama that are tissue specific proteins with higher expres-
sion in spinal cord, brain, adrenal glands. The Mdka protein in zebrafish 
is a heparin-binding growth factor that initiates signaling pathways that 
promote repair, proliferation, and regeneration. Mdka plays a key role in 
the initial stages of zebrafish neurogenesis [56] and is implicated in 
organs development such as heart and retina [57]. L1cama is essential in 
neural migration, axonal growth and maturation of brain and neural 
structures [58]. Those tissue specific mechanisms that could be partially 
impaired by the interaction are related to the protein quality control 
pathways. This is in concordance with TCDD toxic effects described for 
zebrafish embryos, like embryonic brain development capacity reduc-
tion and craniofacial malformations [59], blood flow reduction and 
apoptosis incrementation in the midbrain [60,61], and heart malfor-
mation [62–64]. The elucidation of these mechanisms has begun by 
observations in developmental processes where pathways for midbrain 
circulation failure, circulatory failure and jaw malformation were sug-
gested [65]. Those phenotypic outcomes previously described are 
compatible with the contribution from alteration of the functional 
pathways connected with the identified targets. 
In this second study with a chemical mixture, Tnni2a and Tpm4b are 
proteins targets identified that regulate muscle contraction via calcium 
binding, and the attachment of actin to myosin filaments facilitating 
muscle contraction of cardiac and skeletal muscle. The mutations on 
Tnni2a.4 in zebrafish embryos showed myofibril degradation, inability 
to swim, and failure to inflate the swim bladder [66]. Studies utilizing 
zebrafish embryos exposed to a different type of POP mixtures also 
detected by transcriptomic analysis altered level of troponin [67]. 
Another group of targets, Hrc, Prkcsh, and Lamb2 can also be linked 
with muscle contraction at another level layer of the tissular mechanism. 
Hrc may play a role in the regulation of Ca + 2 storage in the sarco-
plasmic reticulum of skeletal and cardiac muscle, in humans. As a result, 
a deficiency in Hrc provokes heart failure [68]. This PISA analysis also 
identified common targets, such as Trap1 and Calr3b, of TCDD as single 
chemical and as targets of the mixture also containing TCDD. However, 
it is also expected that the global impact of the same targets in mixtures 
could differ from the single chemical case. Considering that chemicals in 
a mixture could interact both with the other chemicals and proteins and 
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may present synergistic or antagonistic interactions [1,69]. 
In the third study, we have selected a new compound from marine 
biodiscovery with only partial chemical and biological characterization. 
The priority for those compounds is to reduce the length and complexity 
of applying numerous individual assays of get sufficient data to predict if 
any beneficial or harmful effects should be expected. For hpa, there was 
only initial phenotypic screenings that indicated possible reduction in 
lipid content in zebrafish embryo [25]. Several of the identified proteins 
were related to metabolic pathways, Gapdh and Pkmb from the glyco-
lytic pathway could interfere in the main cellular energy conversion 
pathway and compromise cellular growth and survival. The target 
Aldh2.2 is key enzyme in ethanol degradation pathway with functional 
similarities to other ALDH enzymes previously identified as hpa target 
with bTPP using hepatic cell line HepG2 [21]. In human, ALDH2 is a 
mitochondrial enzyme that not only metabolizes aldehyde into acetic 
acid but also is involved on detoxification of toxic aldehydes. The in-
crease of toxic aldehydes has been correlated with obesity and insulin 
resistance [70]. ALDH2 deficiency aggravate liver injury and has a 
crucial role in the pathogenesis of liver fibrosis and has been postulated 
for pharmacological strategies against alcohol liver disorders [71]. On 
the other hand, alterations in Glo1, another identified target, could 
reduce the detoxification of methylglyoxal and reactive aldehydes from 
the metabolism. The methylglyoxal mainly derives from oxidation of 
glycolytic intermediates dihydroxyacetone-phosphate and 
glyceraldehyde-3-phosphate. It is a concern the defective methylglyoxal 
detoxification under high nutrition intake is an indicator of suscepti-
bility to develop type 2 diabetes. In zebrafish, the knockout of Glo1 
induces impaired glucose tolerance but does not cause vascular organ 
alterations [72]. The reduction in stability of Dbi, zebrafish target with 
similarity to human acyl-CoA binding protein (ACBP) also suggested 
interaction that would promote functional impairment. A role of appe-
tite regulator factor from ACBP has been recently found to be conserved 
through evolution. In human and rodent, it is a key player in the hy-
perphagia that could be associated to obesity. The attenuation of ACBP 
is correlated in studies in vivo with increase of lipolysis and reduce food 
intake and therefore this target is a suitable candidate for intervention in 
lipid related metabolic alterations [73]. In summary, protein targets 
involved in metabolic pathways could be connect with the phenotype 
from the biodiscovery screening associated with the regulation of lipid 
metabolism and could be related with obesity and obesity-related co- 
morbidities. 
The last study aims to offer a rapid evaluation of possible the side- 
effects of a novel chemical in non-target tissues that is another chal-
lenge of toxicology. We evaluate a new drug in developmental phase 
with promising anti-cancer activity named as EG-011. The 5 identified 
proteins were ubiquitous in the organism and related to protein turn-
over, synthesis and degradation that are abundant proteins of the 
developmental stage of the zebrafish embryo. The specific drug targets 
that are under study both, in vitro and in vivo in lymphoma models were 
not any of the identified proteins in zebrafish proteome. Safety phar-
macology and quality control of new drugs are another pillar of regu-
latory toxicology. To assess the quality of any novel drugs it is required 
the assessment of any unexpected or harmful effects in the non-target 
organs and this application could simplify those studies at the early 
stage of drug development. 
We have discussed the results of this methodology for our cases in the 
context of their specific aims. However, the overarching goal for toxi-
cology is providing a comprehensive evaluation of a proteome for 
possible targets of chemicals, providing knowledge that could bridge the 
gap between molecular interactions and toxicity pathways. It is impor-
tant to remark that most of the proteins scrutinized in this context with 
PISA would have never been studied as target with a single protein 
assay, enhancing this methodology the chances to unravel novel infor-
mation. In spite of that, the validation of solid knowledge is not the 
primary goals of this methodology for toxicology. A priori, applying 
high-throughput methods is apparently not the most efficient strategy 
for validation of well-known targets and mechanism of actions. We have 
previously mentioned case of aryl hydrocarbon receptor for TCDD as a 
well-known target that is not into the studied proteome and therefore 
would not be an identified target with this methodology [74]. Finally, 
when newly scrutinized targets are obtained, it is recommendable to 
validate by an alternative, and ideally orthogonal, methodology. This 
should be the directions to explore for the results obtained by this 
method. Unfortunately, the validation strategies are not free from 
drawbacks. It not easy validate proteins that are not frequently required 
for functional assays or interaction assays. Orthogonal validation has 
been presented for protein targets from drugs analyzed by thermal 
proteome profiling methods. In that study the novel targets identified by 
isothermal shift assay, only protein kinases, could directly validate by a 
kinase affinity enrichment assay [75]. Any orthogonal validation should 
also evaluate the interaction in the proteome wide context, where 
complex milieu is ruling affinities for binding. In drug discovery work, 
purified proteins have been validated by differential scanning fluorim-
etry that could also assay chemical unfolding but it has recently 
described as prone to false positives and negatives [76]. 
5. Conclusions 
We showed that the systematic analysis of chemical-protein in-
teractions by PISA could identify the molecular interactions, that could 
cover gaps to define the interference on cellular functions, and aid in 
predicting the biological consequence in zebrafish embryo. This analysis 
should incorporate both the protein increasing and decreasing in solu-
bility as all contribute to offer an overview of the interference. This 
application of a high-throughput thermal shift assay could contribute to 
address several challenges of toxicology including to predict the impact 
of exposure to individual chemical, mixtures of chemical, new chemicals 
from biodiscovery, or side-effects of newly developed chemicals. We 
anticipate that this PISA assay could bridge the gap between molecular 
interactions and toxicity pathways. 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.jprot.2021.104382. 
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